Citius Oncology, Inc. CTOR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s total liabilities?
- Citius Oncology, Inc. (CTOR) reported total liabilities of $65.43M in Q1 2026.
- How has Citius Oncology, Inc.'s total liabilities changed year-over-year?
- Citius Oncology, Inc.'s total liabilities increased by 17.3% year-over-year, from $55.8M to $65.43M.
- What is the long-term trend for Citius Oncology, Inc.'s total liabilities?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s total liabilities has grown at a 58.9% compound annual growth rate (CAGR), from $22.2M to $56.08M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.